These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 2208163)
1. Cytotoxicity, radiosensitization, antitumor activity, and interaction with hyperthermia of a Co(III) mustard complex. Teicher BA; Abrams MJ; Rosbe KW; Herman TS Cancer Res; 1990 Nov; 50(21):6971-5. PubMed ID: 2208163 [TBL] [Abstract][Full Text] [Related]
2. Interaction with hyperthermia of tetrachloroplatinum(II)(Nile blue)2 and tetrachloroplatinum(II)(neutral red)2 in EMT6 murine cells and the murine FSaIIC fibrosarcoma. Herman TS; Teicher BA; Pfeffer MR; Khandekar VS; Korbut TT Cancer Res; 1990 Jul; 50(13):3826-31. PubMed ID: 2354434 [TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity, radiosensitization, and DNA interaction of platinum complexes of thiazin and xanthene dyes. Teicher BA; Herman TS; Kaufmann ME Radiat Res; 1990 Feb; 121(2):187-95. PubMed ID: 2305037 [TBL] [Abstract][Full Text] [Related]
4. Lonidamine as a modulator of alkylating agent activity in vitro and in vivo. Teicher BA; Herman TS; Holden SA; Epelbaum R; Liu SD; Frei E Cancer Res; 1991 Feb; 51(3):780-4. PubMed ID: 1988117 [TBL] [Abstract][Full Text] [Related]
5. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma. Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474 [TBL] [Abstract][Full Text] [Related]
6. Combined modality therapy with bleomycin, hyperthermia, and radiation. Teicher BA; Herman TS; Holden SA Cancer Res; 1988 Nov; 48(22):6291-7. PubMed ID: 2460220 [TBL] [Abstract][Full Text] [Related]
7. Interaction of PtCl4(Fast Black)2 with hyperthermia. Teicher BA; Herman TS; Pfeffer MR; Alvarez Sotomayor E; Khandekar VS Cancer Res; 1989 Nov; 49(22):6208-13. PubMed ID: 2804969 [TBL] [Abstract][Full Text] [Related]
8. Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma. Teicher BA; Holden SA; al-Achi A; Herman TS Cancer Res; 1990 Jun; 50(11):3339-44. PubMed ID: 2334928 [TBL] [Abstract][Full Text] [Related]
9. DNA interaction, cytotoxicity, and radiosensitization with PtCl4(Nile Blue)2 and PtCl4(Neutral Red)2. Teicher BA; Herman TS; Kaufmann ME Radiat Res; 1989 Oct; 120(1):129-39. PubMed ID: 2798776 [TBL] [Abstract][Full Text] [Related]
10. Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in mice. Cantrell JE; Green D; Schein PS Cancer Res; 1986 May; 46(5):2340-3. PubMed ID: 2938728 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of pentoxifylline as a modulator of alkylating agent activity in vitro and in vivo. Teicher BA; Holden SA; Herman TS; Epelbaum R; Pardee AB; Dezube B Anticancer Res; 1991; 11(4):1555-60. PubMed ID: 1746913 [TBL] [Abstract][Full Text] [Related]
12. Effect of hypoxia and acidosis on the cytotoxicity of four platinum complexes at normal and hyperthermic temperatures. Herman TS; Teicher BA; Collins LS Cancer Res; 1988 May; 48(9):2342-7. PubMed ID: 3356002 [TBL] [Abstract][Full Text] [Related]
13. Addition of 2-nitroimidazole radiosensitizers to cis-diamminedichloroplatinum(II) with radiation and with or without hyperthermia in the murine FSaIIC fibrosarcoma. Herman TS; Teicher BA; Holden SA; Pfeffer MR; Jones SM Cancer Res; 1990 May; 50(9):2734-40. PubMed ID: 2139359 [TBL] [Abstract][Full Text] [Related]
14. Interaction of SR-4233 with hyperthermia and radiation in the FSaIIC murine fibrosarcoma tumor system in vitro and in vivo. Herman TS; Teicher BA; Coleman CN Cancer Res; 1990 Aug; 50(16):5055-9. PubMed ID: 2379171 [TBL] [Abstract][Full Text] [Related]
15. Effect of hyperthermia on the action of cis-diamminedichloroplatinum(II), rhodamine 123(2) [tetrachloroplatinum(II)], rhodamine 123, and potassium tetrachloroplatinate in vitro and in vivo. Herman TS; Teicher BA; Chan V; Collins LS; Kaufmann ME; Loh C Cancer Res; 1988 May; 48(9):2335-41. PubMed ID: 3356001 [TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity. Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355 [TBL] [Abstract][Full Text] [Related]
17. Preclinical studies and clinical correlation of the effect of alkylating dose. Frei E; Teicher BA; Holden SA; Cathcart KN; Wang YY Cancer Res; 1988 Nov; 48(22):6417-23. PubMed ID: 3180059 [TBL] [Abstract][Full Text] [Related]
18. Interaction of platinum(II) tetrachlorodianion (Fast Black)2 with superhelical DNA and with radiation in vitro and in vivo. Teicher BA; Herman TS; Kaufmann ME Radiat Res; 1989 Jul; 119(1):134-44. PubMed ID: 2756104 [TBL] [Abstract][Full Text] [Related]
19. In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride. Berners-Price SJ; Mirabelli CK; Johnson RK; Mattern MR; McCabe FL; Faucette LF; Sung CM; Mong SM; Sadler PJ; Crooke ST Cancer Res; 1986 Nov; 46(11):5486-93. PubMed ID: 3756897 [TBL] [Abstract][Full Text] [Related]
20. Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines. Teicher BA; Cucchi CA; Lee JB; Flatow JL; Rosowsky A; Frei E Cancer Res; 1986 Sep; 46(9):4379-83. PubMed ID: 3731096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]